Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells.

Autor: Effat, Heba1 (AUTHOR) hebatullah.effat@nci.cu.edu.eg, Abosharaf, Hamed A.2 (AUTHOR), Radwan, Aliaa M.2 (AUTHOR) alyaa_radwan@science.tanta.edu.eg
Zdroj: Scientific Reports. 2/3/2024, Vol. 14 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje